UnitedHealth Group's Q3 earnings call revealed a strong performance across its businesses, with revenue growth of 7% year-over-year and earnings per share growth of 7% to $1.63. The company raised its net earnings projection to a range of $5.60 to $5.65 per share, and its guidance for 2015 suggests continued growth. The call also highlighted the company's focus on cost management, value-based care, and consumer engagement, as well as its expansion into international markets and Optum's growth in health services. Overall, the company's performance and guidance suggest a positive outlook for the stock.

[1]